EPO and polycythemia: Modulation of endogenous EPO signaling in mice with Von Hippel–Lindau (VHL) mutation in osteoblasts caused an increase in hypoxia inducible factor-1/2 (HIF), resulting in elevated EPO production in osteoblasts and polycythemia (Rankin et al., 2012).